CPC A61K 31/4535 (2013.01) [A23L 33/10 (2016.08); A61K 45/06 (2013.01); A61P 35/00 (2018.01)] | 5 Claims |
1. A method for treating breast cancer, the method comprising a step of administering to a subject in need thereof pharmaceutical composition containing a compound represented by the following Formula 1 or a pharmaceutically acceptable salt thereof,
wherein the breast cancer is triple-negative breast cancer or Herceptin-resistant breast cancer:
|